Carna Biosciences Inc. | Cash Flow
Fiscal year is January-December. All values JPY Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
279,003.00
844,836.00
486,090.00
288,926.00
733,380.00
Depreciation, Depletion & Amortization
37,590.00
67,520.00
19,219.00
21,801.00
12,114.00
Other Funds
43,000.00
-
6,265.00
-
99.00
Funds from Operations
231,516.00
554,539.00
539,460.00
448,057.00
683,457.00
Changes in Working Capital
15,518.00
85,563.00
137,815.00
4,910.00
122,402.00
Net Operating Cash Flow
247,034.00
468,976.00
401,645.00
452,967.00
561,055.00
Capital Expenditures
7,643.00
41,850.00
3,000.00
31,070.00
38,130.00
Purchase/Sale of Investments
-
-
-
281,876.00
-
Net Investing Cash Flow
8,576.00
41,826.00
3,000.00
248,004.00
38,131.00
Issuance/Reduction of Debt, Net
6,394.00
20,342.00
52,741.00
481,484.00
45,600.00
Net Financing Cash Flow
701,124.00
66,574.00
602,938.00
754,897.00
295,814.00
Net Change in Cash
455,576.00
440,827.00
998,198.00
536,245.00
304,967.00
Free Cash Flow
254,677.00
509,961.00
398,877.00
484,037.00
599,068.00
Net Assets from Acquisitions
933.00
-
-
-
-
Other Sources
-
24.00
-
-
-
Change in Capital Stock
651,730.00
46,232.00
543,932.00
273,412.00
369,541.00
Exchange Rate Effect
10,062.00
3,401.00
3,385.00
13,689.00
1,595.00
Other Uses
-
-
-
2,802.00
-
About Carna Biosciences
View Profile
